A Study Of Human Papillomavirus (Hpv) Screening For Detection Of Cervical Cancer In Pregnancy And Postpartum

Abstract

Gynecological malignant tumours during pregnancy have increased in recent years, mostly due to an increase in the number of older women having pregnancies. Cervical cancer accounts for 71.6 percent of all pregnancy-related gynaecological malignancies, followed by ovarian malignancies at 7.0 percent. Cervical cancer in pregnant women is uncommon, and the symptoms are often mistaken for those of other illnesses. Misdiagnosis is more common during pregnancy since gynaecological examinations are restricted. Pregnancy-related cervical cancer treatment is dependent on a variety of variables, including tumour size and type, gestational length, lymph node involvement, and the willingness of the patient to carry the pregnancy to full term. Due of this, it is difficult to decide the best course of treatment. Cervical cancer in pregnancy can be diagnosed and treated effectively while protecting the fetus's health and avoiding delays in treatment and preterm births. This article highlights the latest research on the diagnosis and treatment principles of cervical cancer in pregnancy.